Upgrade to SI Premium - Free Trial

Pre-Open Stock Movers 8/16: (STEM) (ANTH) (EBIO) Higher; (OGXI) (HAIN) (HTBX) Lower

August 16, 2016 9:27 AM
OncoGenex Pharmaceuticals, Inc. (Nasdaq: OGXI) 34.3% LOWER; announced results from the final analysis of AFFINITY, the Phase 3 trial of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Special Reports

Next Articles